No Picture
News

BioLogiQ Announces a Breakthrough NuPlastiQ® BioBlend® XN for use in Polypropylene Non-woven Applications Bringing Expanded Performance and Price-competitive Bio-based Content to this Valuable Market

IDAHO FALLS, Idaho: IDAHO FALLS, Idaho, Aug. 31, 2021 /PRNewswire/ — BioLogiQ, Inc., a global innovator and manufacturer of plant-based biopolymers for use in the production of plastic products, announced today that it has developed a NuPlastiQ BioBle… […]

No Picture
News

Valued to be $11.2 Billion by 2026, Antimicrobial Textiles Slated for Robust Growth Worldwide

SAN FRANCISCO: SAN FRANCISCO, Aug. 31, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Antimicrobial Textiles – Global Market Trajecto… […]

No Picture
News

SR One leads $55M round for nasal alternative to EpiPen; Sanofi pulls website over accuracy concerns

California-based biopharma company ARS Pharmaceuticals said today that they have closed on a Series D round of $55 million. The round was led by SR One, with RA Capital Management and Deerfield Management participating. ARS is using the money to advanc… […]

No Picture
News

BC Platforms Launches packaged end-to-end solution for NGS laboratories with Sentieon to accelerate adoption of NGS testing

ZURICH and SAN JOSE, Calif.: BC|GENOME X-10 provides a complete solution for high quality, high throughput NGS laboratory operations. ZURICH and SAN JOSE, Calif., Aug. 31, 2021 /PRNewswire/ — BC Platforms (BCP), a global leader in healthcare data mana… […]

No Picture
News

Leading Global Influencer Marketing Agency, MG Empower acquired by US-headquartered Amyris, Inc.

LONDON: LONDON, Aug. 31, 2021 /PRNewswire/ — Leading global influencer marketing agency, MG Empower has been acquired by US-headquartered Amyris, a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through… […]

No Picture
News

Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics’ RheOx™ System for Chronic Bronchitis

SAN CARLOS, Calif.: SAN CARLOS, Calif., Aug. 31, 2021 /PRNewswire/ — Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced new data from multiple clinical studies that demonstrate improvements in ch… […]